Pheromone Sciences Corp.
TSX VENTURE : PHS

Pheromone Sciences Corp.

April 03, 2006 11:51 ET

Pheromone Sciences Increases Private Placement

KELOWNA, BRITISH COLUMBIA--(CCNMatthews - April 3, 2006) - Pheromone Sciences Corp. ("Pheromone") (TSX VENTURE:PHS) announces that further to its release on March 20, 2006, Pheromone has increased the private placement to a maximum of $3,000,000.

The private placement is subject to regulatory and TSX Venture Exchange approvals.

Pheromone Sciences Corp. is a biotechnology and medical diagnostics device research and development company that focuses on commercializing medical technologies.

ON BEHALF OF THE BOARD

Dev Randhawa, President


Contact Information

  • Pheromone Sciences Corp.
    Mr. Phil Morehouse
    (250) 868-8177
    (250) 868-8493 (FAX)